Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex
Clinical trial NCT03715478 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03715478
- Sponsor
- Canadian Myeloma Research Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-26
- Primary completion
- 2025-06-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.